Biotech, Healthcare & Wellness Intel

FinCanna Capital Corp.
Latest Comments

André Larente provides an update on the ‘exponential growth’ of the Diagnos AI-based telemedicine platform

In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente, President of Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) […]

Eyes on DIAGNOS as commercialization gains momentum

The best time to buy an emerging company is when it begins commercialization. At this stage all the hard years […]

Patient Heal Thyself.

Many, many years ago I worked in the crude oil marketing business with a gentleman (and I use that term […]

Entrepreneur Stuart Lowther ‘Rejuvenates’ the nutraceutical sector with Element Nutritional Sciences

Element Nutritional Sciences Inc. (CSE: ELMT | FRANKFURT: 93X) (“Element”) is a listed nutraceutical company based in Ontario, Canada, founded […]

Thomas Smeenk with an update on the FDA Phase II clinical trial program of the Hemostemix blood-derived, stem cell therapeutics product (ACP-01)

In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV: HEM | […]

Awakn announces first-ever study investigating ketamine in gambling addiction treatment

When we think about addiction many people think about drugs, tobacco, and alcohol addiction; but often forget about gambling addiction. […]

Rapidly expanding U.S. distribution is becoming a Rritual for this Superfood company

To succeed in most businesses you need a good product, good marketing and good distribution. It also helps if your […]

XPhyto Therapeutics Corp.